134 related articles for article (PubMed ID: 28278149)
1. [Socioeconomic Costs of Asthma in the European Union, United States and Canada: A Systematic Review].
Puig-Junoy J; Pascual-Argenté N
Rev Esp Salud Publica; 2017 Mar; 91():. PubMed ID: 28278149
[TBL] [Abstract][Full Text] [Related]
2. The Economic Burden of Asthma in the United States, 2008-2013.
Nurmagambetov T; Kuwahara R; Garbe P
Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
[TBL] [Abstract][Full Text] [Related]
3. Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies.
Puig-Junoy J; Ruiz Zamora A
Semin Arthritis Rheum; 2015 Apr; 44(5):531-541. PubMed ID: 25511476
[TBL] [Abstract][Full Text] [Related]
4. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of severe asthma exacerbations in Spain: multicentre observational study.
Quirce S; Melero C; Huerta A; Uría E; Cuesta M
J Asthma; 2021 Feb; 58(2):207-212. PubMed ID: 31621441
[No Abstract] [Full Text] [Related]
6. Economic impact of severe asthma in Spain: multicentre observational longitudinal study.
Melero Moreno C; Quirce S; Huerta A; Uría E; Cuesta M
J Asthma; 2019 Aug; 56(8):861-871. PubMed ID: 30003827
[No Abstract] [Full Text] [Related]
7. Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.
Sicras-Mainar A; Capel M; Navarro-Artieda R; Nuevo J; Orellana M; Resler G
J Med Econ; 2020 May; 23(5):492-500. PubMed ID: 31958257
[No Abstract] [Full Text] [Related]
8. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
9. Asthma-related resource use and cost by GINA classification of severity in three European countries.
Van Ganse E; Antonicelli L; Zhang Q; Laforest L; Yin DD; Nocea G; Sazonov Kocevar V
Respir Med; 2006 Jan; 100(1):140-7. PubMed ID: 16338597
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
[TBL] [Abstract][Full Text] [Related]
11. Asthma severity and medical resource utilisation.
Antonicelli L; Bucca C; Neri M; De Benedetto F; Sabbatani P; Bonifazi F; Eichler HG; Zhang Q; Yin DD
Eur Respir J; 2004 May; 23(5):723-9. PubMed ID: 15176687
[TBL] [Abstract][Full Text] [Related]
12. Incremental direct expenditure of treating asthma in the United States.
Kamble S; Bharmal M
J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
[TBL] [Abstract][Full Text] [Related]
13. Clinical, economic, and humanistic burden of asthma in Canada: a systematic review.
Ismaila AS; Sayani AP; Marin M; Su Z
BMC Pulm Med; 2013 Dec; 13():70. PubMed ID: 24304726
[TBL] [Abstract][Full Text] [Related]
14. European Union-28: An annualised cost-of-illness model for venous thromboembolism.
Barco S; Woersching AL; Spyropoulos AC; Piovella F; Mahan CE
Thromb Haemost; 2016 Apr; 115(4):800-8. PubMed ID: 26607486
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of the patient-level cost of asthma care in children.
Ungar WJ; Coyte PC;
Pediatr Pulmonol; 2001 Aug; 32(2):101-8. PubMed ID: 11477726
[TBL] [Abstract][Full Text] [Related]
16. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
17. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study.
Chen W; Safari A; FitzGerald JM; Sin DD; Tavakoli H; Sadatsafavi M
Thorax; 2019 Dec; 74(12):1113-1119. PubMed ID: 31534029
[TBL] [Abstract][Full Text] [Related]
19. The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence.
Perry R; Braileanu G; Palmer T; Stevens P
Pharmacoeconomics; 2019 Feb; 37(2):155-167. PubMed ID: 30315512
[TBL] [Abstract][Full Text] [Related]
20. The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study.
Rovira J; Albarracin G; Salvador L; Rejas J; Sánchez-Iriso E; Cabasés JM
Community Ment Health J; 2012 Jun; 48(3):372-83. PubMed ID: 22484993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
